HPV-associated oropharyngeal cancer de-escalation strategies and trials: Past failures and future promise Review


Authors: Zakeri, K.; Dunn, L.; Lee, N.
Review Title: HPV-associated oropharyngeal cancer de-escalation strategies and trials: Past failures and future promise
Abstract: HPV-associated oropharynx squamous cell carcinomas are radiosensitive and chemosensitive, thus, portending a favorable prognosis. Treatment de-intensification strategies aim to reduce toxicity while maintaining efficacy. Although approaches that have substituted cisplatin with cetuximab or omitted chemotherapy have not been successful, Transoral Robotic Surgery with de-intensified adjuvant therapy has been promising. Additionally, personalized approaches are taking advantage of tumor biology and utilizing tumor reduction or hypoxia on imaging as a predictive marker to successfully de-escalate radiotherapy and chemotherapy. © 2021 Wiley Periodicals LLC
Keywords: oropharynx cancer; treatment de-escalation; hpv-associated
Journal Title: Journal of Surgical Oncology
Volume: 124
Issue: 6
ISSN: 0022-4790
Publisher: Wiley Blackwell  
Date Published: 2021-11-01
Start Page: 962
End Page: 966
Language: English
DOI: 10.1002/jso.26696
PROVIDER: scopus
PUBMED: 34595766
DOI/URL:
Notes: Review -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Y. Lee
    871 Lee
  2. Lara   Dunn
    141 Dunn
  3. Kaveh Zakeri
    81 Zakeri